Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
1. autor: | Moreino, Shannon Sherwin |
---|---|
Kolejni autorzy: | Kabir, Eva Rahman |
Format: | Project report |
Język: | English |
Wydane: |
BRAC University
2018
|
Hasła przedmiotowe: | |
Dostęp online: | http://hdl.handle.net/10361/9331 |
Podobne zapisy
-
Biologics and Biosimilars as Treatment Options for Psoriasis
od: Moya, Amena Khatun
Wydane: (2023) -
Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Wydane: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
od: Tabassum, Turana
Wydane: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
od: Tania, Umme
Wydane: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Wydane: (2023)